AMGEN Inc
NASDAQ: AMGN
$293.54
-$4.24 (-1.4%)
Closing Price on February 7, 2025
AMGN Articles
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St.research calls this Friday morning. Amgen Inc. (NASDAQ: AMGN) raised to Overweight at Piper Jaffray....
Published:
Last Updated:
We have many stocks on the move in the after-hours session. Today was the largest day for S&P earnings this earnings season. Some of these volume spikes are massive. Acme Packet, Inc....
Published:
Last Updated:
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a 13% revenue gain to $4.5 billion and adjusted earnings rose 34% to...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Wednesday morning. Amgen Corp. (NASDAQ: AMGN) raised to Outperform at Credit...
Published:
Last Updated:
Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and short of it is that the mandate is constitutional as a tax after a 5-4...
Published:
Last Updated:
24/7 Wall St. loves companies which send capital back to shareholders via dividends. With all of the uncertainty in today’s markets and in the fluctuating economy, having a solid dividend policy...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this week. ...
Published:
Last Updated:
Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St. has provided some detailed previews for the key earnings reports we expect to show in detail on...
Published:
Last Updated:
AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As Streetinsider.com points out, the company’s new chairman presided over...
Published:
You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion mark. You might have even read the scores of recommendations about what it should do with all...
Published:
Last Updated:
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all day. About half an hour before closing, all three indexes are down...
Published:
Last Updated:
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at Bernstein....
Published:
Last Updated:
The three major US stock indexes opened a bit higher this morning, and after some volatility have managed to get to the final half hour of trading with a modest gain. Some news is leaking out about...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.